malondialdehyde has been researched along with enalapril in 27 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (14.81) | 18.2507 |
| 2000's | 15 (55.56) | 29.6817 |
| 2010's | 8 (29.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kato, M; Nagano, M; Takeda, N; Yang, J | 1 |
| Kedziora-Kornatowska, K; Luciak, M | 1 |
| Armas de Hernández, MJ; Armas-Padilla, MC; Carvajal, AR; Guerrero-Pajuelo, J; Hernández-Hernández, R; Pacheco, B; Velasco, M | 1 |
| Carrasquedo, F; de Cavanagh, EM; Ferder, L; Fraga, CG; Inserra, F; Scrivo, D; Wassermann, A | 1 |
| Brosh, D; Levi, Z; Lidar, M; Rachmani, R; Ravid, M | 1 |
| Kedziora-Kornatowska, KZ; Luciak, M; Paszkowski, J | 1 |
| Arinsoy, T; Derici, U; Donmez, G; Erbas, D; Hasanoglu, E; Onk, A; Sindel, S | 1 |
| Akula, A; Kota, MK; Routhu, KV; Veeravalli, KK | 1 |
| Akula, A; Veeravalli, KK | 1 |
| Boonyen, M; Futrakul, N; Futrakul, P; Patumraj, S; Siriviriyakul, P; Tosukhowong, P | 1 |
| Imai, E; Moriyama, T; Oka, K; Ueda, H | 1 |
| Chen, SX; Liu, LY; Liu, YH; Sun, YX; Wu, JX | 1 |
| Lin, H; Lin, ST; Qi, XM; Qian, H; Wu, GZ; Wu, YG; Zhao, M | 1 |
| Dhalla, NS; Liu, X; Sethi, R; Suzuki, H; Takeda, N; Tappia, PS | 1 |
| Aghaeishahsavari, M; Argani, H; Ghorbanihaghjo, A; Noroozianavval, M; Rashtchizadeh, N; Veisi, P | 1 |
| Aghaeishahsavari, M; Argani, H; Babaei, H; Ghorbanihaghjo, A; Mesgari, M; Noroozianavval, M; Rashtchizadeh, N; Safa, J; Veisi, P | 1 |
| Ghazi-Khansari, M; Ghobadi, G; Karimian, G; Mohammadi-Karakani, A; Shakiba, B; Sotoudeh, M | 1 |
| Chen, SX; Liu, LY; Liu, YH; Song, T; Wu, SJ; Zhou, SH | 1 |
| Ferder, L; Finch, J; Husain, K; Mizobuchi, M; Slatopolsky, E | 1 |
| Ferder, L; Husain, K; Isidro, A; Suarez, E | 1 |
| Adesanoye, OA; Bamidele, TO; Ekor, M; Kale, OE; Odewabi, AO; Oritogun, KS | 1 |
| Banoglu, ZN; Dengiz, GO; Kandemir, NO; Kurcer, Z; Mungan, G; Ozacmak, VH; Turkili, B | 1 |
| Bohlooli, S; Dehghani, GA; Panahpour, H | 1 |
| Abu el Maaty, MA; El-Maraghy, SA; Fahim, AT; Gad, MZ; Hamdy, MA | 1 |
| Hernández-Fonseca, JP; Mosquera, J; Pedreañez, A; Peña, C; Viera, N | 1 |
| Gibas-Dorna, M; Kozlik, J; Krauss, H; Kupsz, J; Mikrut, K; Pruszynska-Oszmałek, E | 1 |
| Lykkesfeldt, J; Petersen, KE; Rakipovski, G; Raun, K | 1 |
5 trial(s) available for malondialdehyde and enalapril
| Article | Year |
|---|---|
Effects of amlodipine and enalapril on platelet function in patients with mild to moderate hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Male; Malondialdehyde; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests | 1999 |
Higher levels of antioxidant defenses in enalapril-treated versus non-enalapril-treated hemodialysis patients.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Catalase; Enalapril; Erythrocytes; Female; Free Radicals; Glutathione; Glutathione Peroxidase; Humans; Kidney Failure, Chronic; Lipid Peroxidation; Male; Malondialdehyde; Mice; Middle Aged; Reactive Oxygen Species; Renal Dialysis; Ubiquinone; Vitamin E | 1999 |
Oxidation of low-density lipoprotein in normotensive type 2 diabetic patients. Comparative effects of enalapril versus nifedipine: a randomized cross-over over study.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diabetes Mellitus, Type 2; Enalapril; Female; Humans; Lipid Peroxidation; Lipoproteins, LDL; Male; Malondialdehyde; Middle Aged; Nifedipine; Single-Blind Method; Thiobarbituric Acid Reactive Substances | 2000 |
Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Cross-Over Studies; Enalapril; Female; Humans; Kidney Transplantation; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sequence Analysis, DNA | 2007 |
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Cell Cycle Proteins; Deoxyguanosine; DNA Damage; Enalapril; Female; Humans; Kidney Transplantation; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Renin-Angiotensin System | 2008 |
22 other study(ies) available for malondialdehyde and enalapril
| Article | Year |
|---|---|
The effects of angiotensin converting enzyme inhibitors and the role of the renin-angiotensin-aldosterone system in J-2-N cardiomyopathic hamsters.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cardiomyopathies; Creatine Kinase; Cricetinae; Electrocardiography; Enalapril; Fructose-Bisphosphate Aldolase; Heart Ventricles; Kallikrein-Kinin System; Male; Malondialdehyde; Mesocricetus; Myosins; Renin-Angiotensin System | 1992 |
Effect of angiotensin convertase inhibitors on lipid peroxidation and peroxyl radical-trapping capacity in rats with experimental diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Diabetes Mellitus, Experimental; Enalapril; Erythrocytes; Free Radicals; Lipid Peroxidation; Male; Malondialdehyde; Peroxides; Rats; Rats, Wistar | 1998 |
Lipid peroxidation and activities of antioxidant enzymes in the diabetic kidney: effect of treatment with angiotensin convertase inhibitors.
Topics: Albuminuria; Animals; Antioxidants; Blood Glucose; Captopril; Catalase; Diabetes Mellitus, Experimental; Enalapril; Hemoglobin A; Kidney; Lipid Peroxidation; Male; Malondialdehyde; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors | 2000 |
The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Female; Glutathione; Humans; Hypertension; Losartan; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Receptor, Angiotensin, Type 1 | 2002 |
Infarct size limiting effect of apstatin alone and in combination with enalapril, lisinopril and ramipril in rats with experimental myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin; Bradykinin Receptor Antagonists; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Lipid Peroxides; Lisinopril; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Peptides; Ramipril; Rats; Rats, Sprague-Dawley; Time Factors | 2003 |
Involvement of nitric oxide and prostaglandin pathways in the cardioprotective actions of bradykinin in rats with experimental myocardial infarction.
Topics: Animals; Aspirin; Bradykinin; Disease Models, Animal; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Injections, Intravenous; Lisinopril; Male; Malondialdehyde; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; NG-Nitroarginine Methyl Ester; Peptides; Rats; Rats, Sprague-Dawley; Staining and Labeling; Tetrazolium Salts | 2004 |
Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators.
Topics: Adrenal Cortex Hormones; Angiotensin II; Ascorbic Acid; Calcium Channel Blockers; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Enalapril; Endothelial Cells; Glutathione; Humans; Kidney Function Tests; Kidney Glomerulus; Malondialdehyde; Nephrosis; Oxidative Stress; Phytotherapy; Plants, Medicinal; Platelet Aggregation Inhibitors; Proteinuria; Reishi; Renal Circulation; Treatment Outcome; Vasodilator Agents; Vitamin E | 2003 |
Nilvadipine attenuates mesangial expansion and glomerular hypertrophy in diabetic db/db mice, a model for type 2 diabetes.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Blood Pressure; Body Weight; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Glomerular Mesangium; Hypertrophy; Kidney Function Tests; Lipid Peroxidation; Male; Malondialdehyde; Mice; Nifedipine; Organ Size | 2004 |
Comparison of captopril and enalapril to study the role of the sulfhydryl-group in improvement of endothelial dysfunction with ACE inhibitors in high dieted methionine mice.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Animals; Aryldialkylphosphatase; Captopril; Enalapril; Endothelium, Vascular; Male; Malondialdehyde; Methionine; Nitric Oxide; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Superoxide Dismutase; Vasodilation | 2006 |
Renoprotective effects of combination of angiotensin converting enzyme inhibitor with mycophenolate mofetil in diabetic rats.
Topics: Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Animals; Chemokine CCL2; Diabetes Mellitus, Experimental; Drug Therapy, Combination; Enalapril; Immunosuppressive Agents; Intercellular Adhesion Molecule-1; Kidney; Macrophages; Male; Malondialdehyde; Mycophenolic Acid; Oxidative Stress; Rats; Rats, Wistar; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Enalapril; Losartan; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sarcolemma; Sarcoplasmic Reticulum; Ventricular Dysfunction, Left; Ventricular Function, Left | 2006 |
Attenuation of hepatic fibrosis through captopril and enalapril in the livers of bile duct ligated rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Bile Duct Diseases; Captopril; Common Bile Duct; Constriction, Pathologic; Enalapril; Glutathione; Hydroxyproline; Ligation; Liver; Liver Cirrhosis; Male; Malondialdehyde; Rats; Rats, Wistar | 2008 |
Protective effects of ACE inhibitors on vascular endothelial dysfunction induced by exogenous advanced oxidation protein products in rats.
Topics: Acetylcholine; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Urea Nitrogen; Captopril; Creatinine; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Enzyme Inhibitors; Glutathione Peroxidase; Glycation End Products, Advanced; Injections, Intravenous; Kidney; Male; Malondialdehyde; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Serum Albumin, Bovine; Superoxide Dismutase; Vasodilation; Vasodilator Agents | 2008 |
Combination therapy with paricalcitol and enalapril ameliorates cardiac oxidative injury in uremic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Drug Therapy, Combination; Enalapril; Ergocalciferols; Female; Heart Diseases; Malondialdehyde; NADPH Oxidases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Uremia | 2009 |
Effects of paricalcitol and enalapril on atherosclerotic injury in mouse aortas.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Apolipoproteins E; Atherosclerosis; Blood Pressure; Chemokine CCL2; Cyclooxygenase 2; Enalapril; Endothelium; Ergocalciferols; Female; Glutathione; Malondialdehyde; Mice; Mice, Knockout; NADPH Oxidases; Nitric Oxide Synthase; Oxidative Stress; Superoxide Dismutase; Tumor Necrosis Factor-alpha; Vitamins | 2010 |
Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Enalapril; Glutathione; Liver; Losartan; Malondialdehyde; Organ Size; Rats; Rats, Wistar | 2011 |
Role of angiotensin and endothelin in testicular ischemia reperfusion injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Bosentan; Enalapril; Endothelin Receptor Antagonists; Endothelins; Losartan; Male; Malondialdehyde; Rats; Rats, Wistar; Reperfusion Injury; Statistics, Nonparametric; Sulfonamides; Testis | 2012 |
Enalapril attenuates ischaemic brain oedema and protects the blood-brain barrier in rats via an anti-oxidant action.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Blood-Brain Barrier; Brain Edema; Brain Ischemia; Cerebral Arteries; Enalapril; Glutathione; Male; Malondialdehyde; Oxidative Stress; Permeability; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2014 |
Investigating the cardio-protective abilities of supplemental L-arginine on parameters of endothelial function in a hypercholesterolemic animal model.
Topics: Amidohydrolases; Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Cardiotonic Agents; Cardiovascular Diseases; Dietary Supplements; Disease Models, Animal; Enalapril; Endothelium, Vascular; Heart; Hypercholesterolemia; Male; Malondialdehyde; Nitric Oxide; Nitroglycerin; Oxidative Stress; Rabbits | 2014 |
Renal oxidative stress and renal CD8(+) T-cell infiltration in mercuric chloride-induced nephropathy in rats: role of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Catalase; CD8-Positive T-Lymphocytes; Enalapril; Glutathione; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; Mercuric Chloride; Necrosis; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2016 |
Angiotensin-converting enzyme inhibitors reduce oxidative stress intensity in hyperglicemic conditions in rats independently from bradykinin receptor inhibitors.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bradykinin Receptor Antagonists; Captopril; Catalase; Enalapril; Glutathione Peroxidase; Hydrogen Peroxide; Hyperglycemia; Male; Malondialdehyde; Oxidation-Reduction; Oxidative Stress; Rats; Rats, Wistar; Superoxide Dismutase | 2016 |
Brief Communication: Plasma lipid oxidation predicts atherosclerotic status better than cholesterol in diabetic apolipoprotein E deficient mice.
Topics: Animals; Aorta; Apolipoproteins E; Cholesterol; Diabetes Mellitus, Experimental; Enalapril; Lipid Metabolism; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Male; Malondialdehyde; Mice, Knockout; Oxidation-Reduction; Plaque, Atherosclerotic | 2017 |